Related Experiment Videos
Contra-indications to metformin therapy are largely disregarded
A Holstein1, D Nahrwold, S Hinze
11st Department of Medicine, Klinikum Lippe-Detmold, Germany.
Diabetic Medicine : a Journal of the British Diabetic Association
|September 7, 1999
Summary
A study found that most Type 2 diabetes patients on metformin had contraindications for its use, including heart failure and renal impairment. Despite risks, no cases of lactic acidosis were observed.
Area of Science:
- Endocrinology
- Cardiology
- Nephrology
Background:
- Metformin is a common first-line treatment for Type 2 diabetes.
- Patient monitoring for contraindications is crucial for safe metformin use.
Purpose of the Study:
- To assess current metformin prescribing practices.
- To evaluate the consideration of metformin contraindications in Type 2 diabetes patients.
Main Methods:
- Cross-sectional analysis of 308 Type 2 diabetic patients.
- Inclusion of patients previously treated with metformin on an outpatient basis.
- Comprehensive medical history, physical examination, ECG, and laboratory profiling.
Main Results:
- 73% of patients had contraindications, risk factors, or illnesses requiring metformin discontinuation.
- Major contraindications included heart failure (25%) and renal impairment (19%).
- Risk factors like coronary heart disease (51%) were prevalent; no lactic acidosis cases occurred.
Conclusions:
- A high percentage of patients on metformin had conditions contraindicating its use.
- Despite identified risks, lactic acidosis was not observed in this cohort.
- Further research into optimizing metformin use in complex patient populations is warranted.